
Geoffrey Sklar, M.D. talks about the successes of immunotherapy agents like Opdivo, and where this research is moving in the field of bladder cancer.

Geoffrey Sklar, M.D. talks about the successes of immunotherapy agents like Opdivo, and where this research is moving in the field of bladder cancer.

There is no doubt the Affordable Care Act needs tweaking. But let's not lose these critical pieces.

The Cancer Moonshot may not be gone forever after the presidential election, but how it will continue is still being discussed.

"Real Housewives of Beverly Hills" star Camille Grammer discusses how she worked to diminish the shame behind gynecologic cancers.

Genetics testing may help providers know which patients with breast cancer are at higher risk for venous thromboembolism (VTE).

A diagnosis of metastatic breast cancer can be frightening, but education and new treatments are helping these patients adjust to their "new normal."

Somatuline Depot is being explored for patients with lung neuroendocrine tumors.

Treatment advances, including a three-drug combo, are improving outcomes for patients with myeloma.

A recent study examined the link between depression and lung cancer outcomes in patients who are newly diagnosed.

Breast cancer patients with weakened immune systems need to be protected, especially during flu season.

A woman won a lawsuit against Johnson & Johnson, claiming that its baby powder caused her ovarian cancer.

CURE spoke with an expert on the importance of classifying T-cell lymphomas and what is next in this field.

Many female survivors of cancer face sexual pain after treatment, and may not feel comfortable starting a conversation with their health care providers.

A six-year breast cancer survivor and three-year melanoma survivor reflects back and offers hope.

Opdivo had positive results in patients with advanced bladder cancer according to findings from the CheckMate-275 trial.

The FDA granted ribociclib a priority review to a new drug application for certain patients with breast cancer.

In an interview with CURE, James Allison, Ph.D. talks about the progress immunotherapy has made, as well as potential combinations with immunotherapy and other treatment types to provide better outcomes for patients.

Lynparza imrpoved progresion-free survival (PFS) when compared to the placebo group in a phase 3 ovarian cancer trial.

Patients with cognitive impairments from cancer treatment may be able to boost their brain power with a new online tool.

A new online tool can help patients with lymphedema through short exercise videos.

Sometimes you can find comfort and a little bit of relief in an irrational (and a bit silly) behavior.

CURE spoke with Scott Richard, M.D., about ovarian cancer recurrence and barriers women may face the second time around.

The FDA granted brigatinib a priority review for the treatment of certain patients with non-small cell lung cancer.

Treatment and imaging advancements are drastically changing the landscape of sarcoma care.

Breast cancer is filled with surprises and unexpected challenges.

A new policy laid out by the U.S. Department of Health and Human Services is aimed at improving clinical trials.

While colorectal cancer on the left side may have a survival benefit, the stage of the cancer may pay an important role.

A new online tool will help patients with cancer engage in clearer, more meaningful conversations with their care providers.

The recent screening of the Moving Mountains for Multiple Myeloma documentary got people asking, "Where's your Kilimanjaro?"

Patients with activated B-cell-like lymphoma may not respond to standard treatment, so new options are being explored.